| A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorub | Phase II | rekrutiert |
| A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed | Phase III | rekrutiert |
| A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world Sett | — | rekrutiert |
| A Contrast Medium Sparing Strategy Using Automated CO2 Injection During PVI for Prevention of Ma | Phase III | rekrutiert |
| A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradi | Phase III | rekrutiert |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Scle | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo i | Phase III | rekrutiert |
| A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan | Phase III | rekrutiert |
| A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With A | — | rekrutiert |
| A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carbopla | Phase III | rekrutiert |
| A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet | Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosi | Phase III | rekrutiert |
| A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD | Phase III | rekrutiert |
| A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic | Phase III | rekrutiert |
| A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone | Phase III | rekrutiert |
| A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin | — | rekrutiert |
| A Study of Brenipatide in Adult Participants With Major Depressive Disorder | Phase III | rekrutiert |
| A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Canc | — | rekrutiert |
| A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treate | — | rekrutiert |
| A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in P | Phase III | rekrutiert |
| A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) | Phase III | rekrutiert |
| A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoP | — | rekrutiert |
| A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-li | Phase III | rekrutiert |
| A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy | Phase II | rekrutiert |
| A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking | Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Parti | Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + | Phase III | rekrutiert |
| A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab P | Phase III | rekrutiert |
| A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients W | Phase II | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzhe | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cir | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major De | Phase II | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus | Phase II / Phase III | rekrutiert |
| A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by | Phase III | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Pl | Phase III | rekrutiert |
| A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Particip | Phase II | rekrutiert |
| A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomi | Phase III | rekrutiert |
| Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochem | Phase III | rekrutiert |
| An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients | — | rekrutiert |
| An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-ter | Phase III | rekrutiert |
| Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment | — | rekrutiert |
| Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | — | rekrutiert |
| Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD | Phase III | rekrutiert |
| Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refrac | Phase I / Phase II | rekrutiert |
| Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute My | Phase I / Phase II | rekrutiert |
| Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lym | Phase II | rekrutiert |
| Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracra | ohne Phasenangabe | rekrutiert |
| Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Ol | Phase II | rekrutiert |
| Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Re | Phase IV | rekrutiert |
| DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrol | Phase III | rekrutiert |
| EASY Algorithm Trial (Elbow Trauma Assessment Using Sonography in Children and Youth) Diagnostic | — | rekrutiert |
| ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP) | — | rekrutiert |
| Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia | Phase II | rekrutiert |
| European Disease Registry on Retinopathy of Prematurity (ROP) | — | rekrutiert |
| Eye Diseases "Treated" With Interoperable Medical Informatics | — | rekrutiert |
| FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab i | Phase II / Phase III | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| GMMG Multiple Myeloma Registry | — | rekrutiert |
| GMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5 | Phase II | rekrutiert |
| Glycolytic Phenotype (vLapeak) and Magnitude of Skeletal Muscle Hypertrophy After Resistance Tra | ohne Phasenangabe | rekrutiert |
| IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors | Phase I / Phase II | rekrutiert |
| ITP Registry and Accompanying Biospecimen Collection | — | rekrutiert |
| Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multi | Phase III | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| Long-term Evaluation of the Efficacy and Safety of Splentis for the Treatment of Primary Apical | — | rekrutiert |
| Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elev | Phase III | rekrutiert |
| Met Non Small Cell Cancer Registry (MOMENT) | — | rekrutiert |
| Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection | — | rekrutiert |
| NIS to Examine Disease Activity in SLE Patients Treated With Subcutaneous Anifrolumab in Routine | — | rekrutiert |
| NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High- | — | rekrutiert |
| NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-ne | Phase III | rekrutiert |
| Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in A | Phase III | rekrutiert |
| Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial | Phase II / Phase III | rekrutiert |
| Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in | Phase III | rekrutiert |
| Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - POR | Phase III | rekrutiert |
| Praegnant Breast Cancer: Early/Advanced/Metastatic | — | rekrutiert |
| Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer | Phase III | rekrutiert |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blin | Phase II | rekrutiert |
| Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD- | Phase III | rekrutiert |
| Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years Wi | — | rekrutiert |
| Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Pro | — | rekrutiert |
| Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib | Phase III | rekrutiert |
| Safety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate Cancer | Phase II | rekrutiert |
| Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for P | Phase III | rekrutiert |
| Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Inve | Phase II / Phase III | rekrutiert |
| Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) | Phase III | rekrutiert |
| Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available The | Phase III | rekrutiert |
| Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior | — | rekrutiert |
| Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-sm | Phase II / Phase III | rekrutiert |
| Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Folli | Phase III | rekrutiert |
| Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resect | Phase III | rekrutiert |
| Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated E | Phase III | rekrutiert |
| Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in T | Phase III | rekrutiert |
| Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positi | Phase III | rekrutiert |
| Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma | Phase I / Phase II | rekrutiert |
| Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Im | Phase III | rekrutiert |
| Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL | Phase II | rekrutiert |
| Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination | Phase III | rekrutiert |
| Terumo Aortic Global Endovascular Registry | — | rekrutiert |
| The PERSEVERE Study | ohne Phasenangabe | rekrutiert |
| This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plu | Phase III | rekrutiert |
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM AL | Phase III | rekrutiert |
| Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-ga | Phase III | rekrutiert |
| Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed | Phase II | rekrutiert |